Published by Michele Maatouk on 1st October 2025
(Sharecast News) - US President Donald Trump's 'Most Favoured Nation' deal with Pfizer could be a bellwether for the pharmaceutical sector and reassure investors over a broadly manageable impact, JPMorgan said in a research note
URL: http://www.digitallook.com/dl/news/story/35392030/...